Turkey's Abdi Ibrahim acquires 28.5% share of OM Pharma

[Saithan]

BY DAILY SABAH
ISTANBUL BUSINESS
SEP 18, 2020 11:51 AM GMT+3

General view of Abdi İbrahim production complex in Istanbul’s Esenyurt district. (Photo Courtesy of Abdi İbrahim)


Turkey’s leading pharmaceutical company Abdi Ibrahim on Friday acquired 28.5% of the shares of Switzerland-based biotech company OM Pharma for TL 4.2 billion ($530 million), becoming the firm's second-largest shareholder.

Chairman of Abdi Ibrahim, Nezih Barut, said at an online meeting that the acquisition talks that were launched on Jan. 23 were positively concluded late Thursday.
“We submitted the best offer,” he said.

The chairman noted that the perception that "Turkish companies are sold to foreign firms" has changed, adding that they will jointly produce some chemicals and biotechnological drugs with OM Pharma.

Biotechnological drugs constitute around 20% of the global pharmaceutical market. The market size of this region will reach $445 billion in 2019. It is estimated that the share of biotech in all drug-diagnostic products will reach 80% by 2030.


Turkey's biotech pharmaceutical market has reached TL 3.4 billion ($54.78 million). Thirty-one of the 100 best-selling drugs in Turkey are biotechnological products, with a market share of around 17%.

source: https://www.dailysabah.com/business...of-om-pharma/news?gallery_image=undefined#big

________________________________

This is how we want things done. Buy companies and make sure the turnover comes to Turkey!

 

[Luwian]

Sound like a good business deal for Abdi Ibrahim however especially in CH there are couple of companies which dominete the world wide monopol of gbobal pharmaceutical market. when it comes to a parting of the way, so human or porift then it goes always for protit! ...regardless ethic or moral.

Also some companies might choose CH in mid of europe to be close to the market as well to bypass eu law constraints in terms of health and safety.
I belive Türkiye has a better practise - in favor of the patient, at least in certain areas.

 

[Ryder]

Forgive me I literally thought this was a Somali owned company.

 

[Huelague]

BY DAILY SABAH
ISTANBUL BUSINESS
SEP 18, 2020 11:51 AM GMT+3

General view of Abdi İbrahim production complex in Istanbul’s Esenyurt district. (Photo Courtesy of Abdi İbrahim)


Turkey’s leading pharmaceutical company Abdi Ibrahim on Friday acquired 28.5% of the shares of Switzerland-based biotech company OM Pharma for TL 4.2 billion ($530 million), becoming the firm's second-largest shareholder.

Chairman of Abdi Ibrahim, Nezih Barut, said at an online meeting that the acquisition talks that were launched on Jan. 23 were positively concluded late Thursday.
“We submitted the best offer,” he said.

The chairman noted that the perception that "Turkish companies are sold to foreign firms" has changed, adding that they will jointly produce some chemicals and biotechnological drugs with OM Pharma.

Biotechnological drugs constitute around 20% of the global pharmaceutical market. The market size of this region will reach $445 billion in 2019. It is estimated that the share of biotech in all drug-diagnostic products will reach 80% by 2030.


Turkey's biotech pharmaceutical market has reached TL 3.4 billion ($54.78 million). Thirty-one of the 100 best-selling drugs in Turkey are biotechnological products, with a market share of around 17%.

source: https://www.dailysabah.com/business...of-om-pharma/news?gallery_image=undefined#big

________________________________

This is how we want things done. Buy companies and make sure the turnover comes to Turkey!

???